Falcone A - Search Results

1

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D. Van Cutsem E, et al. Among authors: falcone a. Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5. Ann Oncol. 2016. PMID: 27380959 Free article.

2

Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.

Onetto M, Bruzzone M, Conte PF, Ruvolo M, Conio A, Chiara S, Falcone A, Bentivoglio G, Serra GE, Paganuzzi M. Onetto M, et al. Among authors: falcone a. Oncology. 1989;46(2):117-22. doi: 10.1159/000226697. Oncology. 1989. PMID: 2710476

3

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study.

Falcone A, Pfanner E, Cianci C, Danesi R, Brunetti I, Del Tacca M, Conte PF. Falcone A, et al. Cancer. 1995 Jan 15;75(2):440-3. doi: 10.1002/1097-0142(19950115)75:2<440::aid-cncr2820750205>3.0.co;2-3. Cancer. 1995. PMID: 7812913 Clinical Trial.

4

Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.

Falcone A, Pfanner E, Ricci S, Bertuccelli M, Cianci C, Carrai M, De Marco S, Ceribelli A, Barduagni M, Calabresi F, et al. Falcone A, et al. Ann Oncol. 1994 Oct;5(8):760-2. doi: 10.1093/oxfordjournals.annonc.a058983. Ann Oncol. 1994. PMID: 7826910 Free article. Clinical Trial.

5

Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: clinical evidence of incomplete cross-resistance.

Falcone A, Cianci C, Pfanner E, Bertuccelli M, Brunetti I, Muttini MP, Dargenio F, Ricci S, Conte PF. Falcone A, et al. Ann Oncol. 1994 Mar;5(3):291. doi: 10.1093/oxfordjournals.annonc.a058813. Ann Oncol. 1994. PMID: 8186179 Free article. Clinical Trial. No abstract available.

6

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

Rosso R, Mazzei T, Sobrero A, Mini E, Cartei G, Conte P, Labianca R, Cartei F, Falcone A, Pancera G, et al. Rosso R, et al. Among authors: falcone a. Eur J Cancer. 1994;30A(3):338-43. doi: 10.1016/0959-8049(94)90253-4. Eur J Cancer. 1994. PMID: 8204356 Clinical Trial.

7

Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients.

Falcone A, Danesi R, Dargenio F, Pfanner E, Brunetti I, Del Tacca M, Nethersell AB, Conte PF. Falcone A, et al. J Clin Oncol. 1996 Mar;14(3):729-36. doi: 10.1200/JCO.1996.14.3.729. J Clin Oncol. 1996. PMID: 8622018 Clinical Trial.

8

Treatment of metastatic renal cell carcinoma with constant-rate floxuridine infusion plus recombinant alpha 2b-interferon.

Falcone A, Cianci C, Pfanner E, Ricci S, Lencioni M, Brunetti I, Giulianotti PC, Vannucci L, Mosca F, Conte PF. Falcone A, et al. Ann Oncol. 1996 Aug;7(6):601-5. doi: 10.1093/oxfordjournals.annonc.a010677. Ann Oncol. 1996. PMID: 8879374 Free article. Clinical Trial.

9

Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.

Falcone A, Lencioni M, Brunetti I, Pfanner E, Allegrini G, Antonuzzo A, Andreuccetti M, Malvaldi G, Danesi R, Del Tacca M, Conte PF. Falcone A, et al. Ann Oncol. 1997 Jun;8(6):539-45. doi: 10.1023/a:1008249803523. Ann Oncol. 1997. PMID: 9261522 Free article. Clinical Trial.

10

Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients.

Falcone A, Di Paolo A, Masi G, Allegrini G, Danesi R, Lencioni M, Pfanner E, Comis S, Del Tacca M, Conte P. Falcone A, et al. J Clin Oncol. 2001 Aug 1;19(15):3456-62. doi: 10.1200/JCO.2001.19.15.3456. J Clin Oncol. 2001. PMID: 11481350 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

680 results

Search Page